You are here

exa-cel

Where Will Vertex Pharmaceuticals Be in 10 Years?

Where Will Vertex Pharmaceuticals Be in 10 Years?

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

sickle cell disease

Flag link:

Cell & Gene Therapy Space Gears Up for First CRISPR Approval

Cell & Gene Therapy Space Gears Up for First CRISPR Approval

BioSpace

sickle cell disease

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says

Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says

Fierce Pharma

Vertex Pharmaceuticals

sickle cell disease

Flag link:

As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations

As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations

Fierce Pharma

Vertex Pharmaceuticals

Flag link:

Two Sickle Cell Disease Gene Therapies May Soon Be Approved By FDA

Two Sickle Cell Disease Gene Therapies May Soon Be Approved By FDA

Forbes

sickle cell disease

Vertex Pharmaceutical

CRISPR Therapeutics

Flag link:

FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study

FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study

Yahoo/Reuters

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

Tracking the FDA’s meeting on Vertex, CRISPR’s sickle cell therapy

Tracking the FDA’s meeting on Vertex, CRISPR’s sickle cell therapy

BioPharma Dive

Vertex Pharmaceuticals

sickle cell disease

Flag link:

FDA Flags Off-Target Effects of Vertex, CRISPR’s Sickle Cell Therapy Ahead of Adcomm

FDA Flags Off-Target Effects of Vertex, CRISPR’s Sickle Cell Therapy Ahead of Adcomm

BioSpace

Vertex Pharmaceuticals

sickle cell disease

Flag link:

Vertex gearing up for launch as sickle cell therapy review advances

Vertex gearing up for launch as sickle cell therapy review advances

BioPharma Dive

Vertex Pharmaceuticals

sickle cell disease

Flag link:

First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results

First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results

Clinical Trials Arena

Vertex Pharmaceuticals

beta thalassemia

Flag link:

Could This Move Make Vertex's Next Blockbuster Even Bigger?

Could This Move Make Vertex's Next Blockbuster Even Bigger?

Motley Fool

Vertex Pharmaceuticals

beta thalassemia

sickle cell disease

Flag link:

Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

Yahoo/Businesswire

Vertex Pharmaceuticals

CRISPR Therapeutics

sickle cell disease

beta thalassemia

Flag link:

Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy

Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy

Fierce Biotech

Vertex Pharmaceuticals

antibody-drug conjugate

Flag link:

Vertex Teases Launch of Landmark CRISPR Therapy

Vertex Teases Launch of Landmark CRISPR Therapy

BioSpace

Vertex Pharmaceuticals

sickle cell disease

Flag link:

EMA validates Vertex's CRISPR application, clearing barrier on road to landmark approval

EMA validates Vertex's CRISPR application, clearing barrier on road to landmark approval

Fierce Biotech

Vertex Pharmaceuticals

CRISPR Therapeutics

sickle cell disease

Flag link:

Vertex given green light to seek US approval of CRISPR-based therapy

Vertex given green light to seek US approval of CRISPR-based therapy

BioPharma Dive

Vertex Pharmaceuticals

CRISPR Therapeutics

beta thalassemia

sickle cell disease

Flag link: